A Theos, BR Korf, P Principles - Annals of internal medicine, 2006 - Am Coll Physicians N eurofibromatoses are a set of inherited disorders, des- ignated as neurofibromatosis type 1
(NF1), neurofi- bromatosis type 2 (NF2), and schwannomatosis, that tend to result in the development
of benign tumors of the nerve sheath. The 3 entities are distinguished by specific clinical ... Cited by 50 - Related articles - BL Direct - All 15 versions
JH Tonsgard - Seminars in pediatric neurology, 2006 - Elsevier Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with variable expression.
The complications are age specific. Neurologic complications include tumors of the peripheral
nerves, nerve roots, and plexi; spinal cord compression; dural ectasias; learning ... Cited by 28 - Related articles - All 6 versions
B Barkan, S Starinsky, E Friedman, R Stein, Y Kloog - Clinical Cancer Research, 2006 - AACR Results: The MPNST cell lines were biallelic, NF1 inactive, and neurofibromin deficient. We show
that FTS treatment shortened the relatively long duration of Ras activation and signaling to extracellular
signal-regulated kinase, Akt, and RalA in all NF1-deficient MPNST cell lines (NF1 cells) to ... Cited by 15 - Related articles - BL Direct - All 5 versions
[CITATION] Neurofibromatose: clínica, genética e terapêutica
- ►bmj.com L Messiaen, V Riccardi, J Peltonen, O Maertens, T … - British Medical …, 2003 - jmg.bmj.com The neurofibromatoses are a group of neurocutaneous disorders that show extreme clinical heterogeneity
and are characterised by growth abnormalities in tissues derived from the embryonic neural
crest. 1, 2 Two main clinical forms exist, type 1 (NF1) and type 2 (NF2), as well as several ... Cited by 15 - Related articles - BL Direct - All 6 versions
C Flotho, D Steinemann, CG Mullighan, G Neale, K … - Oncogene, 2007 - nature.com Juvenile myelomonocytic leukemia (JMML) is a malignant hematopoietic disorder whose proliferative
component is a result of RAS pathway deregulation caused by somatic mutation in the RAS or
PTPN11 oncogenes or in patients with underlying neurofibromatosis type 1 (NF-1), by ... Cited by 22 - Related articles - BL Direct - All 4 versions
- ►prsjournal.com K Yohay - The Neurologist, 2006 - journals.lww.com Neurofibromatosis was widely recognized first in the late 1800s when Friedrich von Recklinghausen
described a series of patients with a combination of cutaneous lesions and peripheral and central
nervous system tumors. It was not until early in the 20th century that neurofibromatosis ... Cited by 21 - Related articles - BL Direct - All 3 versions
[CITATION] Aspectos ortopédicos clínicos da neurofibromatose
MAN Mibielli, D Moreti, BRT Argollo, M Geller, A … - … : clínica, genética e terapêutica …, 2004 Cited by 3 - Related articles
M Geller, A Bonalumi Filho, FC França, FP Nunes - J. bras. med, 1998 - bases.bireme.br Nesta continuação da revisão bibliográfica sobre a síndrome de Von Recklinghausen
(neurofibromatose) abordaremos as desordens de aprendizado e comunicação que ocorrem
mais freqüentemente em crianças e adolescentes com NF1 do que na população em ... Cited by 3 - Related articles - Cached - All 2 versions
